299 related articles for article (PubMed ID: 29728514)
21. Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice.
Hillerdal V; Ramachandran M; Leja J; Essand M
BMC Cancer; 2014 Jan; 14():30. PubMed ID: 24438073
[TBL] [Abstract][Full Text] [Related]
22. Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.
Krenciute G; Prinzing BL; Yi Z; Wu MF; Liu H; Dotti G; Balyasnikova IV; Gottschalk S
Cancer Immunol Res; 2017 Jul; 5(7):571-581. PubMed ID: 28550091
[TBL] [Abstract][Full Text] [Related]
23. [
Zettlitz KA; Tsai WK; Knowles SM; Salazar FB; Kobayashi N; Reiter RE; Wu AM
Mol Imaging Biol; 2020 Apr; 22(2):367-376. PubMed ID: 31209779
[TBL] [Abstract][Full Text] [Related]
24. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
25. Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with
Patrick PS; Kolluri KK; Zaw Thin M; Edwards A; Sage EK; Sanderson T; Weil BD; Dickson JC; Lythgoe MF; Lowdell M; Janes SM; Kalber TL
Stem Cell Res Ther; 2020 Jun; 11(1):256. PubMed ID: 32586403
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution of Mesenchymal Stromal Cells Labeled with [
Astrelina TA; Brunchukov VA; Kodina GE; Bubenshchikov VB; Larenkov AA; Lunev AS; Petrosova KA; Rastorgueva AA; Kobzeva IV; Usupzhanova DY; Nikitina VA; Malsagova KA; Kulikova LI; Samoilov AS; Pustovoyt VI
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894647
[TBL] [Abstract][Full Text] [Related]
27. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET.
Simonetta F; Alam IS; Lohmeyer JK; Sahaf B; Good Z; Chen W; Xiao Z; Hirai T; Scheller L; Engels P; Vermesh O; Robinson E; Haywood T; Sathirachinda A; Baker J; Malipatlolla MB; Schultz LM; Spiegel JY; Lee JT; Miklos DB; Mackall CL; Gambhir SS; Negrin RS
Clin Cancer Res; 2021 Feb; 27(4):1058-1068. PubMed ID: 33087332
[TBL] [Abstract][Full Text] [Related]
28. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
Krebs S; Ahad A; Carter LM; Eyquem J; Brand C; Bell M; Ponomarev V; Reiner T; Meares CF; Gottschalk S; Sadelain M; Larson SM; Weber WA
J Nucl Med; 2018 Dec; 59(12):1894-1900. PubMed ID: 29903928
[TBL] [Abstract][Full Text] [Related]
29. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
Al-Saden N; Lam K; Chan C; Reilly RM
Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM.
Warnders FJ; Waaijer SJ; Pool M; Lub-de Hooge MN; Friedrich M; Terwisscha van Scheltinga AG; Deegen P; Stienen SK; Pieslor PC; Cheung HK; Kosterink JG; de Vries EG
J Nucl Med; 2016 May; 57(5):812-7. PubMed ID: 26848172
[TBL] [Abstract][Full Text] [Related]
31. Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling.
Bansal A; DeGrado TR; Pandey MK
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955388
[TBL] [Abstract][Full Text] [Related]
32. T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells.
Yang D; Sun B; Dai H; Li W; Shi L; Zhang P; Li S; Zhao X
J Immunother Cancer; 2019 Jul; 7(1):171. PubMed ID: 31288857
[TBL] [Abstract][Full Text] [Related]
33. Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with
Jacob J; Volpe A; Peng Q; Lechler RI; Smyth LA; Lombardi G; Fruhwirth GO
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771148
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow cell homing to sites of acute tibial fracture:
Asiedu KO; Ferdousi M; Ton PT; Adler SS; Choyke PL; Sato N
EJNMMI Res; 2018 Dec; 8(1):109. PubMed ID: 30547233
[TBL] [Abstract][Full Text] [Related]
35. Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models.
Volpe A; Lang C; Lim L; Man F; Kurtys E; Ashmore-Harris C; Johnson P; Skourti E; de Rosales RTM; Fruhwirth GO
Mol Ther; 2020 Oct; 28(10):2271-2285. PubMed ID: 32645298
[TBL] [Abstract][Full Text] [Related]
36. Molecular Imaging of Radiolabeled Bispecific T-Cell Engager
Waaijer SJH; Warnders FJ; Stienen S; Friedrich M; Sternjak A; Cheung HK; van Scheltinga AGTT; Schröder CP; de Vries EGE; Lub-de Hooge MN
Clin Cancer Res; 2018 Oct; 24(20):4988-4996. PubMed ID: 29980531
[No Abstract] [Full Text] [Related]
37. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
38. Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
Hegde M; Mukherjee M; Grada Z; Pignata A; Landi D; Navai SA; Wakefield A; Fousek K; Bielamowicz K; Chow KK; Brawley VS; Byrd TT; Krebs S; Gottschalk S; Wels WS; Baker ML; Dotti G; Mamonkin M; Brenner MK; Orange JS; Ahmed N
J Clin Invest; 2016 Aug; 126(8):3036-52. PubMed ID: 27427982
[TBL] [Abstract][Full Text] [Related]
39. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
40. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
